KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)

Q: What does CUSIP 483497103 represent in this 13F holders report?

CUSIP 483497103 is the security identifier for KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in Q2 2019?

74 institutional investors reported KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share for Q2 2019. Use the holders table for investor-level position and value details.

CUSIP: 483497103

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 50,580,036
Total 13F shares: 14,786,402
Share change: +881,174
Total reported value: $327,505,666
Price per share: $22.15
Number of holders: 74
Value change: +$6,277,733
Number of buys: 43
Number of sells: 33

Quarterly Holders Quick Answers

What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 483497103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SV Health Investors, LLC	13F	Company	3.6%	1,831,548	$52,419,000	—	31 Mar 2019	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	2.8%	1,441,070	$41,243,000	—	31 Mar 2019	13F
Vivo Capital, LLC	13F	Company	2.7%	1,359,149	$38,899,000	—	31 Mar 2019	13F
Polar Capital LLP	13F	Company	2.3%	1,149,200	$32,890,000	—	31 Mar 2019	13F
VHCP Management III, LLC	13F	Company	1.9%	970,630	$27,779,000	—	31 Mar 2019	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.8%	900,000	$25,758,000	—	31 Mar 2019	13F
FMR LLC	13F	Company	1.5%	735,014	$21,036,000	—	31 Mar 2019	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.3%	665,000	$19,032,000	—	31 Mar 2019	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1.3%	650,000	$18,603,000	—	31 Mar 2019	13F
VHCP Management II, LLC	13F	Company	1.1%	573,482	$16,413,000	—	31 Mar 2019	13F
Ghost Tree Capital, LLC	13F	Company	0.79%	400,000	$11,448,000	—	31 Mar 2019	13F
INTERWEST VENTURE MANAGEMENT CO	13F	Company	0.77%	388,766	$11,126,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	0.71%	357,390	$10,228,000	—	31 Mar 2019	13F
Invesco Ltd.	13F	Company	0.62%	313,791	$8,980,000	—	31 Mar 2019	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.42%	213,061	$6,062,000	—	31 Mar 2019	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.41%	205,500	$5,881,000	—	31 Mar 2019	13F
Boxer Capital, LLC	13F	Company	0.4%	200,000	$5,724,000	—	31 Mar 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.32%	159,929	$4,577,000	—	31 Mar 2019	13F
Samsara BioCapital, LLC	13F	Company	0.23%	118,500	$3,391,000	—	31 Mar 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.19%	96,470	$2,761,000	—	31 Mar 2019	13F
ORBIMED ADVISORS LLC	13F	Company	0.18%	90,500	$2,590,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.16%	83,095	$2,378,000	—	31 Mar 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.14%	72,547	$2,076,000	—	31 Mar 2019	13F
Fosun International Ltd	13F	Company	0.14%	72,606	$2,028,000	—	31 Mar 2019	13F
BlackRock Finance, Inc.	13F	Company	0.14%	70,257	$2,011,000	—	31 Mar 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.12%	62,062	$1,776,000	—	31 Mar 2019	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.12%	60,000	$1,717,000	—	31 Mar 2019	13F
Laurion Capital Management LP	13F	Company	0.12%	58,871	$1,685,000	—	31 Mar 2019	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.11%	54,000	$1,545,000	—	31 Mar 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.1%	48,060	$1,375,000	—	31 Mar 2019	13F
WEDGE CAPITAL MANAGEMENT L L P/NC	13F	Company	0.09%	45,905	$1,314,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	0.08%	40,900	$1,170,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.07%	37,790	$1,082,000	—	31 Mar 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.07%	34,607	$990,000	—	31 Mar 2019	13F
Neuberger Berman Group LLC	13F	Company	0.07%	33,500	$959,000	—	31 Mar 2019	13F
BARCLAYS PLC	13F	Company	0.06%	32,489	$930,000	—	31 Mar 2019	13F
MARSHALL WACE, LLP	13F	Company	0.06%	29,452	$843,000	—	31 Mar 2019	13F
Tibra Equities Europe Ltd	13F	Company	0.05%	25,401	$727,000	—	31 Mar 2019	13F
Informed Momentum Co LLC	13F	Company	0.05%	23,830	$682,000	—	31 Mar 2019	13F
ExodusPoint Capital Management, LP	13F	Company	0.05%	23,253	$666,000	—	31 Mar 2019	13F
DAFNA Capital Management LLC	13F	Company	0.05%	23,225	$665,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.04%	17,787	$508,000	—	31 Mar 2019	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.03%	17,551	$502,000	—	31 Mar 2019	13F
ALGERT GLOBAL LLC	13F	Company	0.03%	16,591	$475,000	—	31 Mar 2019	13F
CITIGROUP INC	13F	Company	0.02%	12,238	$350,000	—	31 Mar 2019	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.02%	11,000	$315,000	—	31 Mar 2019	13F
BlueCrest Capital Management Ltd	13F	Company	0.02%	10,620	$304,000	—	31 Mar 2019	13F
Man Group plc	13F	Company	0.02%	9,381	$268,000	—	31 Mar 2019	13F
STATE STREET CORP	13F	Company	0.02%	8,575	$245,000	—	31 Mar 2019	13F
MORGAN STANLEY	13F	Company	0.01%	7,486	$214,000	—	31 Mar 2019	13F

Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q2 2019

As of 30 Jun 2019, KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,786,402 shares. The largest 10 holders included SV Health Investors, LLC, EVENTIDE ASSET MANAGEMENT, LLC, Polar Capital LLP, Vivo Capital, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FMR LLC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., VHCP Management III, LLC, and VANGUARD GROUP INC. This page lists 74 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Q2 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.